1. Home
  2. ACB vs CCCC Comparison

ACB vs CCCC Comparison

Compare ACB & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACB
  • CCCC
  • Stock Information
  • Founded
  • ACB N/A
  • CCCC 2015
  • Country
  • ACB Canada
  • CCCC United States
  • Employees
  • ACB N/A
  • CCCC N/A
  • Industry
  • ACB Pharmaceuticals and Biotechnology
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACB Health Care
  • CCCC Health Care
  • Exchange
  • ACB Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • ACB 313.7M
  • CCCC 304.8M
  • IPO Year
  • ACB N/A
  • CCCC 2020
  • Fundamental
  • Price
  • ACB $5.75
  • CCCC $6.03
  • Analyst Decision
  • ACB Hold
  • CCCC Buy
  • Analyst Count
  • ACB 1
  • CCCC 7
  • Target Price
  • ACB N/A
  • CCCC $8.71
  • AVG Volume (30 Days)
  • ACB 1.4M
  • CCCC 2.6M
  • Earning Date
  • ACB 08-08-2024
  • CCCC 08-06-2024
  • Dividend Yield
  • ACB N/A
  • CCCC N/A
  • EPS Growth
  • ACB N/A
  • CCCC N/A
  • EPS
  • ACB N/A
  • CCCC N/A
  • Revenue
  • ACB $253,963,971.00
  • CCCC $20,036,000.00
  • Revenue This Year
  • ACB $58.73
  • CCCC $26.24
  • Revenue Next Year
  • ACB $17.34
  • CCCC N/A
  • P/E Ratio
  • ACB N/A
  • CCCC N/A
  • Revenue Growth
  • ACB 98.86
  • CCCC N/A
  • 52 Week Low
  • ACB $2.84
  • CCCC $1.06
  • 52 Week High
  • ACB $11.50
  • CCCC $11.88
  • Technical
  • Relative Strength Index (RSI)
  • ACB 52.57
  • CCCC 57.54
  • Support Level
  • ACB $5.70
  • CCCC $4.36
  • Resistance Level
  • ACB $6.54
  • CCCC $7.66
  • Average True Range (ATR)
  • ACB 0.38
  • CCCC 0.56
  • MACD
  • ACB 0.12
  • CCCC 0.21
  • Stochastic Oscillator
  • ACB 62.05
  • CCCC 50.68

About ACB Aurora Cannabis Inc.

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

Share on Social Networks: